G.P Talwar, Founder-Director of the National Institute of Immunology (NII), has developed a first-of-its-kind leprosy vaccine in India. This indigenous vaccine, mycobacterium indicus pranii, has been approved by the Drug Controller General of India (DGCI) and Food and Drug Administration (FDA) department of the US.
http://www.thebetterindia.com/65669/vaccine-india-cure-leprosy/?utm_source=The+Better+India+Newsletter&utm_campaign=f07f1d25c2-RSS_EMAIL_CAMPAIGN&utm_medium=email&utm_term=0_cd579275a4-f07f1d25c2-74060141
